Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Excellent point thanks for sharing.
That's a great recommendation W.S. GL
I'm sorry I just can't take you seriously. You are a whiny baby.
100% agree! We were at .03 back in august. GL
We getting a little action today!
Great post. I just in late yesterday. GLTA
They already addressed that in a tweet and it has no bearing on the share price.
easy snowflake
CDEL is retail
I 1000% agree with everything you just said. GL
Good Morning, let's get over .004 today. GLTA
Looking forward to updates soon. It's just a matter of time imo.
Does anyone have a link or know what we are waiting on? Thanks for any help.
Great tweet out!!!
With 7 houses sold for the month of November at a average price of $450,000.00 , we are expecting December home sales to be another great month. We are expecting January 2021 home sales to break all previous January sales providing for a very good start for 2021. $XTRM
— Extreme Biodiesel (@XTRMBio) November 30, 2020
If they buy warrants it will not be before February 26, 2021.
It's already part of the unrestricted shares.
Correct let's hope it's over. GL
IMO those are the shares that we recently saw diluted. The 3rd paragraph in the PR says they have 325 in cash flow which is a good sign.
The Company CEO, Shawn Leon, stated, “With these two events, the Company has positively impacted cash flow over the next three months by over $325,000.00. This comes at a critical time and aids our ability to grow the addiction treatment business from start-up to cash flow breakeven.” Mr. Leon added, “The one-time at-the-market conversion and new investment by Labrys was a show of confidence in the results of the restructuring transactions undertaken by the Company.”
Ethema Signs Term Sheet for $275,000 Financing and Eliminates Major Debt with Convertible Note Conversion
https://www.otcmarkets.com/stock/GRST/news/story?e&id=1753839
WEST PALM BEACH, FL, Nov. 30, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – Ethema Health Corporation (OTCPINK: GRST) (“Ethema” “GRST” or the “Company”), is pleased to announce that the Company has signed a term sheet on November 24, 2020 with Labrys Fund LP for a 12% $275,000.00 loan that will provide the Company with a net of $239,050.00 after original interest discounts, legal fees and brokers fees. The loan is repayable in 10 equal monthly payments of $30,800 commencing February 26, 2021. The loan will have full warrant coverage. The warrants will have a term of 5 years and will allow for the purchase of 183,333,333 shares at a price of $.0015 per share.
On November 25, 2020, the Company received a conversion notice (“Notice”) from Labrys Fund LP (“Labrys”) pursuant to the Labrys July 8, 2019 convertible note (“Note”). The Notice was for a conversion of the original principal outstanding under the Note prior to the May 15, 2020 amendment to the Note requiring the Company to pay a reduced principal amount of the Note back in monthly cash installments. The Notice was an at-the-market conversion with a conversion price of $0.0028. The conversion is a one-time conversion that fully satisfies that balance of the Note in excess of $255,000. There was a total of 91,421,457 shares issued under the conversion.
The Company CEO, Shawn Leon, stated, “With these two events, the Company has positively impacted cash flow over the next three months by over $325,000.00. This comes at a critical time and aids our ability to grow the addiction treatment business from start-up to cash flow breakeven.” Mr. Leon added, “The one-time at-the-market conversion and new investment by Labrys was a show of confidence in the results of the restructuring transactions undertaken by the Company.”
The Company expects the cash provided by these events will be sufficient to meet the Company’s operational cash flow requirements for the addiction treatment center start-up. The Company will continue to pursue Regulation A Tier II financing to support accretive acquisitions in the near future.
GM, It's just a waiting game at this point.
Man, you are a baby.
ARIA Treatment Center Receives LegitScript Certification and Blue Cross Provider Number
November 25, 2020 08:45 ET | Source: Ethema Health Corporation
West Palm Beach, FL, Nov. 25, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire --Ethema Health Corporation (OTCPINK: GRST) (“Ethema” “GRST” or the “Company”), is pleased to announce several very positive developments for Evernia Health Center LLC dba ARIA (“ARIA”). On November 24, 2020 ARIA received its LegitScript Certification. LegitScript is the credentialling body that provides certifications, without which companies in the Substance Use Disorder (SUD) industry cannot use pay per click (“PPC”) advertising on Google. ARIA has programmed a large portion of its marketing spend on Google PPC advertising. ARIA engaged the services of Dreamscape Marketing in June 2020 to build its website, manage the website SEO and manage the PPC advertising spend. DreamScape Marketing is a specialist marketing company in the SUD industry and is a very large and successful marketing company serving the SUD industry.
The Company is very pleased with the progress that ARIA has made in the first month of operations and now with the ability to expand the marketing program for the new treatment center, it expects to see rapid growth of the business. The Company is forecasting very strong demand in 2021 for SUD treatment services due to the traumatic effect that the Pandemic has had on so many people and the increases it has caused in substance use.
ARIA will be completing its licensing process in the month of December when the Department of Children and Family services conducts its audit that will change ARIA’s license status from probationary to full license. The audit is normally done within the first 90 days after receiving a new license. This is significant, as the full license status will allow ARIA to complete the process of getting in-network with several large insurers. ARIA has made significant progress on this front and ARIA recently received a provider number from Blue Cross, which it received much sooner than expected, allowing ARIA to admit Blue Cross insured clients.
I have family in town and not paying attention but I’m still in. GLTA
I agree. It's just a waiting game imo. GLTA
Loaded some .0025s today.
LOL, you are kidding right.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159322361
Q out!!! No new shares issued and 1.7M in revenues. Looking good.
XTRM looking good today. Q Monday and news about the 13 upcoming projects any day now.
you have no idea how to read a chart.
New Tweets Out! Clients are loving the facility. Progress on credentialing with insurance companies is ahead of schedule. Looking forward to December licensing inspection for converting probationary license to term license. $GRST
3rd quarter statements in auditor review and expect filing to keep business current. $GRST
Agreed. It's just a matter of time.
Patients pays. GLTA
I'm hoping for news this week. 13 new projects should send this thing flying. GLTA
I’m pretty excited about XTRM. Sounds like lots of updates coming. Also great entry point imo and with this low float it can take off fast.
Attorney Letter Out!!! Attorney Letter with Respect to Current Information
https://backend.otcmarkets.com/otcapi/company/financial-report/262017/content